Drug Type siRNA |
Synonyms Kylo-12 |
Target |
Action inhibitors |
Mechanism APOC3 inhibitors(Apolipoprotein C-III inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hypertriglyceridemia | Phase 1 | China | 12 Mar 2025 |





